The Turkish Journal of Geriatrics (Türk Geriatri Dergisi), with ISSN 1304-2947 and E-ISSN 1307-9948, is a distinguished scholarly publication dedicated to the field of geriatrics and gerontology, proudly published by the Turkish Geriatrics Society. Established to foster knowledge and research in the aging population, this journal plays a crucial role in disseminating significant findings and advancements in the medical care of elderly individuals. Since its inception in 1998, the journal has committed to high-quality, peer-reviewed articles that explore diverse aspects of geriatric medicine, contributing vital insights to practitioners and researchers alike. Although it currently holds a Q4 ranking in the category of Geriatrics and Gerontology, the Turkish Journal of Geriatrics is on an upward trajectory, making it an essential resource for those specializing in the care of older adults. Researchers and professionals are encouraged to explore its rich archive and benefit from the open-access publishing model, promoting broader access to impactful research. For those invested in the well-being of the elderly, the Turkish Journal of Geriatrics serves not only as a platform for scholarly communication but also as a catalyst for innovation in geriatric care.

ANNALS OF PHARMACOTHERAPY, published by SAGE PUBLICATIONS INC, is a leading journal in the realm of pharmacology and therapeutic science, dedicated to advancing research, clinical practice, and education in the field of medicine. With a solid history dating back to its first publication in 1981, this journal offers a platform for high-quality research articles that explore the latest innovations and methodologies in pharmacotherapy. Although it operates under a subscription-based model, the journal maintains a robust academic reputation, reflected in its Scopus ranking in the 68th percentile within the category of Medicine - Pharmacology (Rank #85/272). The impact factor is continually evolving, as is the scope, which encompasses a diverse range of topics from clinical trials to the therapeutic applications of newly-developed drugs. Researchers, professionals, and students alike will find valuable insights and cutting-edge research in the ANNALS OF PHARMACOTHERAPY, making it an essential resource for anyone engaged in the field of pharmacology.

Journal of Frailty & Aging, published by SPRINGER BASEL AG, is a leading platform dedicated to advancing research in the fields of aging, geriatrics, and gerontology. With an ISSN of 2260-1341 and an E-ISSN of 2273-4309, this journal has established itself as a pivotal resource for scholars and practitioners aiming to explore the complexities of frailty and its impact on aging populations. As of 2023, it proudly holds a Q3 classification in Aging and Q2 classifications in both Geriatrics and Gerontology, as well as Physiology (medical), alongside a notable Q1 ranking in Medicine (miscellaneous). The journal's Scopus ranks further reflect its quality and relevance, with rankings as high as #22 in Aging within the Biochemistry, Genetics and Molecular Biology category. The Journal of Frailty & Aging invites contributions that illuminate contemporary challenges and innovations in the field, offering Open Access to enhance the dissemination of knowledge. By publishing rigorous research and impactful reviews, the journal strives to foster a deeper understanding of health and well-being in older adults, making it an essential resource for researchers, healthcare professionals, and students engaged in this vital area of study.

BMC Geriatrics is a leading open-access journal dedicated to advancing the field of geriatrics and gerontology. Published by BMC, this esteemed journal has been at the forefront of research since its inception in 2001, providing a vital platform for sharing innovative studies and insights that address the complexities of aging. With an impressive Q1 ranking in the 2023 category of Geriatrics and Gerontology and a solid Scopus ranking at #40 out of 116, BMC Geriatrics showcases high-impact research that influences clinical practices and policy-making. As a fully open-access publication, it ensures that groundbreaking research is freely available to researchers, practitioners, and students alike, promoting the diffusion of knowledge across the global healthcare community. This journal is crucial for anyone interested in the latest developments in elderly care, health issues affecting aging populations, and innovative interventions designed to improve quality of life among older adults.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

Aging Medicine and Healthcare is a leading Open Access journal dedicated to advancing the understanding of geriatric health and the complexities of aging. Published by the Asia Pacific League Clinical Gerontology & Geriatrics, this innovative journal began its journey in 2019 and has since established itself as an important resource for healthcare professionals, researchers, and students interested in the fields of geriatrics and gerontology. With an impact factor that reflects its growing significance (ranked in the 21st percentile within its category), the journal aims to disseminate high-quality research and practical insights that can inform clinical practice and enhance patient care for aging populations. As an Open Access publication, it ensures that research findings are freely accessible, fostering collaboration and knowledge sharing among academics and practitioners globally. The journal is poised to be a vital platform for innovative studies, systematic reviews, and case reports that illuminate the challenges and opportunities in aging medicine.

The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.

AGE AND AGEING is a premier peer-reviewed journal published by Oxford University Press, dedicated to advancing the field of gerontology and related medical disciplines. With its ISSN of 0002-0729 and E-ISSN 1468-2834, the journal has established itself as a critical platform for disseminating innovative research since its inception in 1972. It boasts impressive rankings within the Q1 category in Aging, Geriatrics and Gerontology, and Miscellaneous Medicine, reflecting its influential position in the scientific community. Researchers and practitioners alike value the journal's focus on the clinical, biological, and social aspects of aging, providing a multidisciplinary approach essential for addressing the challenges of an aging population. The journal maintains a significant impact factor, demonstrating its contribution to scholarly communication and knowledge dissemination. Although it does not operate under an open access model, AGE AND AGEING remains an essential resource for those committed to understanding the complexities of aging and enhancing the quality of life for older adults.

Australian Prescriber is a distinguished open-access journal published by Therapeutic Guidelines Ltd, aiming to advance the field of pharmacology and medical prescriptions. Since its inception in 1994, this journal has been dedicated to disseminating essential findings and insights related to therapeutic guidelines and pharmaceutical care, making it an invaluable resource for healthcare professionals and researchers alike. With an ISSN of 0312-8008 and an E-ISSN of 1839-3942, it caters to an audience that values evidence-based medicine, empowering practitioners with knowledge to enhance clinical practice. The journal currently holds a Q2 ranking in the Pharmacology (medical) category and is recognized in the 51st percentile among its peers, reflecting its significant contributions to the medical field. Available from 1995 to 2024, this journal not only serves as an academic platform but also a critical discussion forum for professionals keen on improving pharmacological practices in Australia and beyond.

DRUGS & THERAPY PERSPECTIVES is an esteemed journal published by SpringerNature, dedicated to advancing knowledge in the field of pharmacology and therapeutic studies. With an ISSN of 1172-0360 and an E-ISSN of 1179-1977, this journal has been providing valuable insights since its inception in 1993 and continues to publish until 2024. Ranked in the Q3 category for Pharmacology (medical) and positioned within the 25th percentile according to Scopus rankings, it serves as a vital resource for researchers, practitioners, and students alike. Although it is not an open-access journal, it offers a comprehensive platform for innovative research, clinical practices, and evolving therapeutic strategies, reflecting the critical developments in drug therapy landscape. With its strategic emphasis on bridging academic studies and clinical applications, DRUGS & THERAPY PERSPECTIVES remains essential for those committed to enhancing drug efficacy and patient outcomes in the ever-evolving medical field.